Danielle Mayorga-Young
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Danielle Mayorga-Young has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Derek Bell
From the Division of Plastic Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, NY
2 shared publications- Jonnby LaGuardia
University of Nevada – Las Vegas
2 shared publications Keith Sweitzer
From the Division of Plastic Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, NY
2 shared publications- Aabra Ahmed
Univ Rochester, Dept Surg, Div Plast & Reconstruct Surg, Med Ctr, 601 Elmwood Ave, Rochester, NY 14642 USA
1 shared publication - Adam Visca
Division of Cardiology, Clinical Cardiovascular Research Center, School of Medicine and Dentistry University of Rochester Rochester New York USA
1 shared publication Antoinette Ba Nguyen
From the Division of Plastic Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, NY
1 shared publication
Latest Publications
- Open Access
- 19 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (10) , 3550
The Impact of Gender-Affirming Hormone Therapy on Seizure Occurrence in Transgender and Gender-Diverse Individuals
Background/Objectives: Gender-affirming hormone therapy (GAHT) is an essential component of care for transgender and gender-diverse (TGD) individuals, yet its impact on seizure occurrence remains unclear. Given the known influence of hormonal fluctuations on seizure activity, this study evaluates whether GAHT affects seizure frequency in TGD individuals with a history of seizures. Methods: We conducted a retrospective cohort study of TGD individuals with a documented history of seizures who initiated GAHT between January 2002 and November 2024. Patients with inadequate follow-up, poor anti-seizure medication adherence, or concurrent feminizing GAHT (FHT) and masculinizing GAHT (MHT) use were excluded. The primary outcome was seizure occurrence before and after GAHT, subdivided into FHT vs. MHT. Results: Of 4391 TGD individuals, 34 met the inclusion criteria. Among 28 patients who had seizures before GAHT, 10 (35.7%) continued to have seizures after, while 18 (64.3%) did not. Seizure occurrence significantly decreased after GAHT: the proportion of individuals who experienced seizures before but not after GAHT was significantly greater than the proportion of individuals who experienced seizures after but not before GAHT (18/34, 52.9%; 6/34, 17.6%; p = 0.025). Among 21 patients on MHT, the proportion of patients who experienced seizures before but not after MHT was greater than the proportion of patients who experienced seizures after but not before MHT, but the difference was not statistically significant (11/21, 52.4%; 3/21, 14.3%; p = 0.06). FHT had no significant impact on seizure occurrence. Conclusions: GAHT was not associated with increased seizure occurrence in this small study. New-onset seizures occurred equally in the FHT and MHT groups, suggesting no disproportionate effect of estrogen-containing regimens. Our results suggest that GAHT might be safe in TGD individuals with epilepsy, though those with poorly controlled seizures may require closer monitoring. Further research may clarify the impact of GAHT on seizure disorders.
- 19 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (10) , 3550
Open AccessThe Impact of Gender-Affirming Hormone Therapy on Seizure Occurrence in Transgender and Gender-Diverse Individuals
Background/Objectives: Gender-affirming hormone therapy (GAHT) is an essential component of care for transgender and gender-diverse (TGD) individuals, yet its impact on seizure occurrence remains unclear. Given the known influence of hormonal fluctuations on seizure activity, this study evaluates whether GAHT affects seizure frequency in TGD individuals with a history of seizures. Methods: We conducted a retrospective cohort study of TGD individuals with a documented history of seizures who initiated GAHT between January 2002 and November 2024. Patients with inadequate follow-up, poor anti-seizure medication adherence, or concurrent feminizing GAHT (FHT) and masculinizing GAHT (MHT) use were excluded. The primary outcome was seizure occurrence before and after GAHT, subdivided into FHT vs. MHT. Results: Of 4391 TGD individuals, 34 met the inclusion criteria. Among 28 patients who had seizures before GAHT, 10 (35.7%) continued to have seizures after, while 18 (64.3%) did not. Seizure occurrence significantly decreased after GAHT: the proportion of individuals who experienced seizures before but not after GAHT was significantly greater than the proportion of individuals who experienced seizures after but not before GAHT (18/34, 52.9%; 6/34, 17.6%; p = 0.025). Among 21 patients on MHT, the proportion of patients who experienced seizures before but not after MHT was greater than the proportion of patients who experienced seizures after but not before MHT, but the difference was not statistically significant (11/21, 52.4%; 3/21, 14.3%; p = 0.06). FHT had no significant impact on seizure occurrence. Conclusions: GAHT was not associated with increased seizure occurrence in this small study. New-onset seizures occurred equally in the FHT and MHT groups, suggesting no disproportionate effect of estrogen-containing regimens. Our results suggest that GAHT might be safe in TGD individuals with epilepsy, though those with poorly controlled seizures may require closer monitoring. Further research may clarify the impact of GAHT on seizure disorders.
- 1 April 2025
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 94 (4S) , S243-S245
Comparison of Operative Efficiency Using Autologous Skin Cell Suspension Versus Standard Split Thickness Autografting
Introduction: Noncultured autologous skin cell suspensions (ASCS) have been applied to burn wounds with comparable results to split-thickness autologous grafts (STSG) while reducing donor graft size and morbidity, making it ideal for patients with large total body surface area (TBSA) burns. However, there is significant cost associated with ASCS. This study aims to compare the size of burn wound coverage per operative minute for ASCS versus STSG, hypothesizing that utilizing ASCS decreases operative time for definitive coverage of large burn wounds, thereby offsetting unit cost. Methodology: This is a case-control study of ASCS surgical encounters in adults versus matched standard-of-care STSG encounters performed by a single burn surgeon at an American Burn Association–verified burn center between September 2015 and August 2024. Patient demographics, burn characteristics, and operative details were collected from electronic medical records. ASCS patients were matched with STSG controls prioritizing total burn surface area and anatomic location, followed by burn etiology, patient age, and sex. Results: Fifty-one ASCS surgeries performed in 45 patients were matched to 51 STSG surgeries performed in 45 patients. The ASCS and STSG groups were similar regarding demographics, hospital length of stay, complication profile, and operative duration. Significantly more square centimeters of wound were treated with ASCS: 2714 ± 1378 versus 1555 ± 1209 (P < 0.0001), and more square centimeters of wound were treated per minute with ASCS over STSG: 34.5 ± 25.4 vs 20.1 ± 10.9 (P = 0.001). Conclusions: Matched groups comparable at baseline demonstrated higher operative efficiency with use of ASCS with similar hospital length of stay and complication profile.
- 1 April 2025
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 94 (4S) , S243-S245
Comparison of Operative Efficiency Using Autologous Skin Cell Suspension Versus Standard Split Thickness Autografting
Introduction: Noncultured autologous skin cell suspensions (ASCS) have been applied to burn wounds with comparable results to split-thickness autologous grafts (STSG) while reducing donor graft size and morbidity, making it ideal for patients with large total body surface area (TBSA) burns. However, there is significant cost associated with ASCS. This study aims to compare the size of burn wound coverage per operative minute for ASCS versus STSG, hypothesizing that utilizing ASCS decreases operative time for definitive coverage of large burn wounds, thereby offsetting unit cost. Methodology: This is a case-control study of ASCS surgical encounters in adults versus matched standard-of-care STSG encounters performed by a single burn surgeon at an American Burn Association–verified burn center between September 2015 and August 2024. Patient demographics, burn characteristics, and operative details were collected from electronic medical records. ASCS patients were matched with STSG controls prioritizing total burn surface area and anatomic location, followed by burn etiology, patient age, and sex. Results: Fifty-one ASCS surgeries performed in 45 patients were matched to 51 STSG surgeries performed in 45 patients. The ASCS and STSG groups were similar regarding demographics, hospital length of stay, complication profile, and operative duration. Significantly more square centimeters of wound were treated with ASCS: 2714 ± 1378 versus 1555 ± 1209 (P < 0.0001), and more square centimeters of wound were treated per minute with ASCS over STSG: 34.5 ± 25.4 vs 20.1 ± 10.9 (P = 0.001). Conclusions: Matched groups comparable at baseline demonstrated higher operative efficiency with use of ASCS with similar hospital length of stay and complication profile.
- 28 November 2024
- Published by Elsevier in Journal of Surgical Education
- Vol. 82 (1) , 103354
The Feasibility and Efficacy of Video Education with Individual Review in Early Surgical Education
- 28 November 2024
- Published by Elsevier in Journal of Surgical Education
- Vol. 82 (1) , 103354
The Feasibility and Efficacy of Video Education with Individual Review in Early Surgical Education
- 9 May 2024
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 46 (1) , 90-93
An Evaluation of Burn Fellowship Program Websites’ Presence and Content
Fellowship program websites pertaining to various subspecialties have been evaluated according to the amount and type of content they communicate to prospective applicants. This study aimed to evaluate what information specifically burn fellowship programs communicate through their websites and to what extent, if at all. In total, 10 of the 30 unique burn fellowship programs, American Burn Association (ABA)-verified or otherwise, identified through the ABA website did not have official websites which could be readily located at the time of data collection. Thus, 20 burn fellowship program websites were included in the analysis. Burn fellowship program websites were assessed according to 23 criteria relating to recruitment, education, and social life. On average, each website contained an average of 8.5 ± 2.6 criteria (range, 2-13), with all of them listing a program contact email/phone, and 95% containing a program description. Only 35% of programs listed the faculty, and a single program advertised alumni job placement. Neither the total number of fellows, the total number of clinical faculty, nor the Accreditation Council for Graduate Medical Education accreditation status were significantly associated with the amount or type of content. Geographic region was associated with a significant difference in the amount of education-related content. Fellowship program websites are important to prospective applicants when comparing programs and deciding where to apply. These results show where burn fellowship programs can increase the amount of publicly available information that applicants tend to find helpful in order to hopefully both diversify and tailor their applicant pool to those whose goals align with the programs’.
- 9 May 2024
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 46 (1) , 90-93
An Evaluation of Burn Fellowship Program Websites’ Presence and Content
Fellowship program websites pertaining to various subspecialties have been evaluated according to the amount and type of content they communicate to prospective applicants. This study aimed to evaluate what information specifically burn fellowship programs communicate through their websites and to what extent, if at all. In total, 10 of the 30 unique burn fellowship programs, American Burn Association (ABA)-verified or otherwise, identified through the ABA website did not have official websites which could be readily located at the time of data collection. Thus, 20 burn fellowship program websites were included in the analysis. Burn fellowship program websites were assessed according to 23 criteria relating to recruitment, education, and social life. On average, each website contained an average of 8.5 ± 2.6 criteria (range, 2-13), with all of them listing a program contact email/phone, and 95% containing a program description. Only 35% of programs listed the faculty, and a single program advertised alumni job placement. Neither the total number of fellows, the total number of clinical faculty, nor the Accreditation Council for Graduate Medical Education accreditation status were significantly associated with the amount or type of content. Geographic region was associated with a significant difference in the amount of education-related content. Fellowship program websites are important to prospective applicants when comparing programs and deciding where to apply. These results show where burn fellowship programs can increase the amount of publicly available information that applicants tend to find helpful in order to hopefully both diversify and tailor their applicant pool to those whose goals align with the programs’.
- 1 April 2024
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 92 (4S) , S200-S203
Plastic Surgery Involvement With Surgical Management of Infected Ventricular Assist Devices Decreased Lifetime Return to Operating Room and 90-Day Infectious Complications
Background The use of left ventricular assist devices (LVADs) for patients with end-stage cardiac failure awaiting heart transplantation has become increasingly common. However, ventricular assist device–related infections remain a major problem complicating their long-term use. Retrospective review has previously shown a decrease in lifetime return to operating room (RTOR) with no change in 90-day complications when a muscle or omental flap is used for coverage after washout for infection. We wished to determine if early plastic surgery intervention led to a decreased length of stay for these patients. Methods Patients with LVAD readmitted for LVAD infection at a single institution from 2008 to 2021 were identified using a preexisting database. Patients were followed retrospectively for an average of 3.2 years. Patient demographics, preoperative diagnosis/disease state, type of ventricular assist device inserted, postoperative day of ventricular assist device infection onset, definitive device coverage, timing of coverage procedure after the initial washout for infection, type of flap used for coverage, 90-day complications after definitive coverage, and lifetime return to operating room for infection were reviewed. Comparison analysis with χ2 and analysis of variance testing was used to analyze outcomes. Results Of 568 patients admitted with an LVAD infection, 104 underwent operative debridement and closure by plastic and reconstructive surgery (PRS) or cardiothoracic surgery (CTS). Fifty-three underwent PRS closure, and 51 underwent CTS closure. There was an increased incidence of diabetes among the PRS group (P < 0.001); otherwise, there was no difference in baseline characteristics. There was increased RTOR over a lifetime with CTS closure compared with PRS (P = 0.03) and increased 90-day risk of infection (P = 0.007). Patients with PRS closure had an increased risk of postoperative hematoma (P = 046). Plastic and reconstructive surgery was typically consulted on hospital day 10. Both PRS and CTS closure patients were discharged on postoperative day 7, on average (P = 0.542). Conclusions Plastic surgery involvement with surgical decision making and closure of infected LVAD devices has a decrease in lifetime RTOR and decreased 90-day complications related to infections. There may be a benefit to earlier PRS consultation for coverage assessment.
- 1 April 2024
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 92 (4S) , S200-S203
Plastic Surgery Involvement With Surgical Management of Infected Ventricular Assist Devices Decreased Lifetime Return to Operating Room and 90-Day Infectious Complications
Background The use of left ventricular assist devices (LVADs) for patients with end-stage cardiac failure awaiting heart transplantation has become increasingly common. However, ventricular assist device–related infections remain a major problem complicating their long-term use. Retrospective review has previously shown a decrease in lifetime return to operating room (RTOR) with no change in 90-day complications when a muscle or omental flap is used for coverage after washout for infection. We wished to determine if early plastic surgery intervention led to a decreased length of stay for these patients. Methods Patients with LVAD readmitted for LVAD infection at a single institution from 2008 to 2021 were identified using a preexisting database. Patients were followed retrospectively for an average of 3.2 years. Patient demographics, preoperative diagnosis/disease state, type of ventricular assist device inserted, postoperative day of ventricular assist device infection onset, definitive device coverage, timing of coverage procedure after the initial washout for infection, type of flap used for coverage, 90-day complications after definitive coverage, and lifetime return to operating room for infection were reviewed. Comparison analysis with χ2 and analysis of variance testing was used to analyze outcomes. Results Of 568 patients admitted with an LVAD infection, 104 underwent operative debridement and closure by plastic and reconstructive surgery (PRS) or cardiothoracic surgery (CTS). Fifty-three underwent PRS closure, and 51 underwent CTS closure. There was an increased incidence of diabetes among the PRS group (P < 0.001); otherwise, there was no difference in baseline characteristics. There was increased RTOR over a lifetime with CTS closure compared with PRS (P = 0.03) and increased 90-day risk of infection (P = 0.007). Patients with PRS closure had an increased risk of postoperative hematoma (P = 046). Plastic and reconstructive surgery was typically consulted on hospital day 10. Both PRS and CTS closure patients were discharged on postoperative day 7, on average (P = 0.542). Conclusions Plastic surgery involvement with surgical decision making and closure of infected LVAD devices has a decrease in lifetime RTOR and decreased 90-day complications related to infections. There may be a benefit to earlier PRS consultation for coverage assessment.